RVL Pharmaceuticals Partners with Santen for Eye Treatment Approval in Japan RVL Pharmaceuticals has collaborated with Santen to receive approval for UPNEEQ® Mini Ophthalmic Solution in Japan, targeting blepharoptosis.

RVL Pharmaceuticals Partners with Santen for Eye Treatment Approval in Japan #Japan #Osaka #Santen #RVL_Pharmaceuticals #Upneeq

RVL Pharmaceuticals Strengthens Leadership to Boost Growth and Market Presence RVL Pharmaceuticals has announced key leadership appointments aimed at accelerating growth and enhancing market presence for its flagship product, Upneeq.

RVL Pharmaceuticals Strengthens Leadership to Boost Growth and Market Presence #USA #Bridgewater #Leadership_Changes #RVL_Pharmaceuticals #Upneeq